BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 12907633)

  • 21. Molecular detection of EWS-Ets fusion transcripts and their clinicopathologic significance in Ewing's sarcoma/peripheral primitive neuroectodermal tumor.
    Wang H; Zheng J; Wang YP; Yang Y; You JF
    Chin Med J (Engl); 2005 Aug; 118(16):1323-9. PubMed ID: 16157025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel zinc finger gene is fused to EWS in small round cell tumor.
    Mastrangelo T; Modena P; Tornielli S; Bullrich F; Testi MA; Mezzelani A; Radice P; Azzarelli A; Pilotti S; Croce CM; Pierotti MA; Sozzi G
    Oncogene; 2000 Aug; 19(33):3799-804. PubMed ID: 10949935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two childhood cases of acute leukemia with t(16;21)(p11.2;q22): second case report of infantile acute lymphoblastic leukemia with unusual type of FUS-ERG chimeric transcript.
    Oh SH; Park TS; Choi JR; Lee S; Cho SY; Kim SY; Kim J; Park JK; Song SA; Lee JY; Shin JH; Kim HR; Lee JN
    Cancer Genet Cytogenet; 2010 Jul; 200(2):180-3. PubMed ID: 20620604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular heterogeneity and function of EWS-WT1 fusion transcripts in desmoplastic small round cell tumors.
    Liu J; Nau MM; Yeh JC; Allegra CJ; Chu E; Wright JJ
    Clin Cancer Res; 2000 Sep; 6(9):3522-9. PubMed ID: 10999739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A practical approach to the clinical diagnosis of Ewing's sarcoma/primitive neuroectodermal tumour and other small round cell tumours sharing EWS rearrangement using new fluorescence in situ hybridisation probes for EWSR1 on formalin fixed, paraffin wax embedded tissue.
    Yamaguchi U; Hasegawa T; Morimoto Y; Tateishi U; Endo M; Nakatani F; Kawai A; Chuman H; Beppu Y; Endo M; Kurotaki H; Furuta K
    J Clin Pathol; 2005 Oct; 58(10):1051-6. PubMed ID: 16189150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.
    Ladanyi M; Lui MY; Antonescu CR; Krause-Boehm A; Meindl A; Argani P; Healey JH; Ueda T; Yoshikawa H; Meloni-Ehrig A; Sorensen PH; Mertens F; Mandahl N; van den Berghe H; Sciot R; Dal Cin P; Bridge J
    Oncogene; 2001 Jan; 20(1):48-57. PubMed ID: 11244503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
    Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
    Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visceral primitive peripheral neuroectodermal tumors: a clinicopathologic and molecular study.
    O'Sullivan MJ; Perlman EJ; Furman J; Humphrey PA; Dehner LP; Pfeifer JD
    Hum Pathol; 2001 Oct; 32(10):1109-15. PubMed ID: 11679946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias.
    Yi H; Fujimura Y; Ouchida M; Prasad DD; Rao VN; Reddy ES
    Oncogene; 1997 Mar; 14(11):1259-68. PubMed ID: 9178886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent rearrangement of the Ewing's sarcoma gene, EWSR1, or its homologue, TAF15, with the transcription factor CIZ/NMP4 in acute leukemia.
    Martini A; La Starza R; Janssen H; Bilhou-Nabera C; Corveleyn A; Somers R; Aventin A; Foà R; Hagemeijer A; Mecucci C; Marynen P
    Cancer Res; 2002 Oct; 62(19):5408-12. PubMed ID: 12359745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fusion of the FUS and CREB3L2 genes in a supernumerary ring chromosome in low-grade fibromyxoid sarcoma.
    Bartuma H; Möller E; Collin A; Domanski HA; Von Steyern FV; Mandahl N; Mertens F
    Cancer Genet Cytogenet; 2010 Jun; 199(2):143-6. PubMed ID: 20471519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.
    Antonescu CR; Tschernyavsky SJ; Decuseara R; Leung DH; Woodruff JM; Brennan MF; Bridge JA; Neff JR; Goldblum JR; Ladanyi M
    Clin Cancer Res; 2001 Dec; 7(12):3977-87. PubMed ID: 11751490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cryptic exons as a source of increased diversity of Ewing tumor-associated EWS-FLI1 chimeric products.
    Kovar H; Jugovic D; Melot T; Zoubek A; Lenoir G; Fink FM; Philip I; Turc-Carel C; Thomas G; Zucman-Rossi J
    Genomics; 1999 Sep; 60(3):371-4. PubMed ID: 10493837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular cytogenetic characterization of four previously established and two newly established Ewing sarcoma cell lines.
    Szuhai K; Ijszenga M; Tanke HJ; Rosenberg C; Hogendoorn PC
    Cancer Genet Cytogenet; 2006 Apr; 166(2):173-9. PubMed ID: 16631476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids.
    Athanasiou M; LeGallic L; Watson DK; Blair DG; Mavrothalassitis G
    Cancer Gene Ther; 2000 Aug; 7(8):1188-95. PubMed ID: 10975680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains.
    Ohno T; Ouchida M; Lee L; Gatalica Z; Rao VN; Reddy ES
    Oncogene; 1994 Oct; 9(10):3087-97. PubMed ID: 8084618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain.
    Prasad DD; Ouchida M; Lee L; Rao VN; Reddy ES
    Oncogene; 1994 Dec; 9(12):3717-29. PubMed ID: 7970732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chimeric EWS-FLI1 transcript in a Ewing cell line with a complex t(11;22;14) translocation.
    Bonin G; Scamps C; Turc-Carel C; Lipinski M
    Cancer Res; 1993 Aug; 53(16):3655-7. PubMed ID: 8339272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma.
    Panagopoulos I; Storlazzi CT; Fletcher CD; Fletcher JA; Nascimento A; Domanski HA; Wejde J; Brosjö O; Rydholm A; Isaksson M; Mandahl N; Mertens F
    Genes Chromosomes Cancer; 2004 Jul; 40(3):218-28. PubMed ID: 15139001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma.
    Riggi N; Cironi L; Provero P; Suvà ML; Stehle JC; Baumer K; Guillou L; Stamenkovic I
    Cancer Res; 2006 Jul; 66(14):7016-23. PubMed ID: 16849546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.